← Back to Search

Cognitive training for Mild Cognitive Impairment

N/A
Waitlist Available
Led By Karen A Chipman, PhD
Research Sponsored by Karen Chipman
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Clinical diagnosis of Mild Cognitive Impairment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at baseline and months 3, 5, 8
Awards & highlights

Study Summary

The purpose of this study is to investigate the feasibility and effectiveness of a cognitive training group in individuals with Mild Cognitive Impairment, using a new paradigm that will optimize ecological validity by (1) focusing on everyday memory problems, (2) supplementing traditional memory training with the teaching of an empirically-supported problem-solving approach, and (3) employing a clinically representative sample of individuals with MCI (e.g., not excluding those with mild affective symptoms).

Eligible Conditions
  • Mild Cognitive Impairment

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at baseline and months 3, 5, 8
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at baseline and months 3, 5, 8 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in everyday memory functioning
Secondary outcome measures
Change in caregiver burden
Change in memory perception
Change in mood (i.e., self-report symptoms of anxiety)
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Cognitive trainingExperimental Treatment1 Intervention
Group II: No cognitive trainingActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive training
2019
Completed Phase 3
~1480

Find a Location

Who is running the clinical trial?

Karen ChipmanLead Sponsor
Nova Scotia Health Research FoundationOTHER_GOV
14 Previous Clinical Trials
34,012 Total Patients Enrolled
Karen A Chipman, PhDPrincipal InvestigatorNova Scotia Health Authority

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Making Memory Better for Seniors With Mild Cognitive Impairment
Karen Chipman 2012. "Making Memory Better for Seniors With Mild Cognitive Impairment". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01532739.
All > Memory > Mild Cognitive Impairment
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top